Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

MannKind Corporation (NASDAQ: MNKD)

 
MNKD Technical Analysis
3
As on 31st Oct 2017 MNKD Share Price closed @ 3.29 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.51 & Buy for SHORT-TERM with Stoploss of 2.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MNKD Share Price

Open 3.46 Change Price %
High 3.50 1 Day -0.14 -4.08
Low 3.28 1 Week 0.00 0.00
Close 3.29 1 Month -1.99 -37.69
Volume 2790695 1 Year 2.63 398.48
52 Week High 6.96 | 52 Week Low 0.46
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
MNKD
Daily Charts		 MNKD
Intraday Charts		 Whats New @
Bazaartrend		 MNKD
Free Analysis
 
MNKD Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE3.49
RESISTANCE3.41
SUPPORT3.17
SUPPORT3.09
SUPPORT0.00
SUPPORT0.00
 
MNKD Target for Month April
Share
4th UP TARGET12.83
3rd UP TARGET9.77
2nd UP TARGET7.88
1st UP TARGET5.99
1st DOWN TARGET0.59
2nd DOWN TARGET-1.3
3rd DOWN TARGET-3.19
4th DOWN TARGET-6.25
 
MNKD Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
MNKD Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
MNKD Other Details
Segment EQ
Market Capital 405527936.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MNKD Address
MNKD
 28903 North Avenue Paine
Valencia, CA 91355
United States
Phone: 661-775-5300
 
MNKD Latest News
 
Your Comments and Response on MannKind Corporation
 
MNKD Business Profile
MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company�s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia. The AFREZZA inhalation powder is centered on a class of potential of hydrogen (pH)-sensitive organic molecules. AFREZZA utilizes its Technosphere formulation technology. As of December 31, 2011, MannKind had not generated any product revenues. As of December 31, 2011, the AFREZZA clinical program had involved 61 different studies of AFREZZA and over 5,600 adult patients.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service